Read More

Quasar Excited to Announce Expansion of Services to Partners in China

A groundbreaking Chinese government policy change in August 2019 by the National Medical Products Administration (NMPA) will now grant any CFDA registered Contract Manufacturer the opportunity to become a Product Registered Manufacturing Contractor in China. Quasar is positioned to expand its abilities to manufacture, obtain necessary cross regional licensing, and participate as a government approved fully licensed registrant.

Read more...